Search Results - "Rushlow, Walter"

Refine Results
  1. 1

    Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation by Hudson, Roger, Renard, Justine, Norris, Christopher, Rushlow, Walter J, Laviolette, Steven R

    Published in The Journal of neuroscience (30-10-2019)
    “…Evidence suggests that the phytocannabinoids Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) differentially regulate salience attribution and psychiatric…”
    Get full text
    Journal Article
  2. 2

    Adolescent Cannabinoid Exposure Induces a Persistent Sub-Cortical Hyper-Dopaminergic State and Associated Molecular Adaptations in the Prefrontal Cortex by Renard, Justine, Rosen, Laura G, Loureiro, Michael, De Oliveira, Cleusa, Schmid, Susanne, Rushlow, Walter J, Laviolette, Steven R

    Published in Cerebral cortex (New York, N.Y. 1991) (01-02-2017)
    “…Considerable evidence suggests that adolescent exposure to delta-9-tetrahydrocanabinol (THC), the psychoactive component in marijuana, increases the risk of…”
    Get full text
    Journal Article
  3. 3

    What Can Rats Tell Us about Adolescent Cannabis Exposure? Insights from Preclinical Research by Renard, Justine, Rushlow, Walter J., Laviolette, Steven R.

    Published in Canadian journal of psychiatry (01-06-2016)
    “…Marijuana is the most widely used drug of abuse among adolescents. Adolescence is a vulnerable period for brain development, during which time various…”
    Get full text
    Journal Article
  4. 4

    Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway by Renard, Justine, Loureiro, Michael, Rosen, Laura G, Zunder, Jordan, de Oliveira, Cleusa, Schmid, Susanne, Rushlow, Walter J, Laviolette, Steven R

    Published in The Journal of neuroscience (04-05-2016)
    “…Schizophrenia-related psychosis is associated with disturbances in mesolimbic dopamine (DA) transmission, characterized by hyperdopaminergic activity in the…”
    Get full text
    Journal Article
  5. 5

    Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function by Renard, Justine, Szkudlarek, Hanna J., Kramar, Cecilia P., Jobson, Christina E. L., Moura, Kyra, Rushlow, Walter J., Laviolette, Steven R.

    Published in Scientific reports (12-09-2017)
    “…Chronic adolescent marijuana use has been linked to the later development of psychiatric diseases such as schizophrenia. GABAergic hypofunction in the…”
    Get full text
    Journal Article
  6. 6

    Effects of Adolescent THC Exposure on the Prefrontal GABAergic System: Implications for Schizophrenia-Related Psychopathology by Renard, Justine, Rushlow, Walter J, Laviolette, Steven R

    Published in Frontiers in psychiatry (02-07-2018)
    “…Marijuana is the most commonly used drug of abuse among adolescents. Considerable clinical evidence supports the hypothesis that adolescent neurodevelopmental…”
    Get full text
    Journal Article
  7. 7

    Inhibition of fatty acid binding protein-5 in the basolateral amygdala induces anxiolytic effects and accelerates fear memory extinction by Jones, Matthew J., Uzuneser, Taygun C., Clement, Timothy, Wang, Hehe, Ojima, Iwao, Rushlow, Walter J., Laviolette, Steven R.

    Published in Psychopharmacology (2024)
    “…Rationale The endocannabinoid (eCB) system critically controls anxiety and fear-related behaviours. Anandamide (AEA), a prominent eCB ligand, is a hydrophobic…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Anxiety and cognitive-related effects of Δ 9-tetrahydrocannabinol (THC) are differentially mediated through distinct GSK-3 vs. Akt-mTOR pathways in the nucleus accumbens of male rats by Hudson, Roger, Norris, Christopher, Szkudlarek, Hanna J., Khan, Dinat, Schmid, Susanne, Rushlow, Walter J., Laviolette, Steven R.

    Published in Psychopharmacology (01-02-2022)
    “…Rationale Δ 9 -tetrahydrocannabinol (THC) is the primary psychoactive compound in cannabis and is responsible for cannabis-related neuropsychiatric side…”
    Get full text
    Journal Article
  11. 11

    Identification of a novel fatty acid binding protein-5-CB2 receptor-dependent mechanism regulating anxiety behaviors in the prefrontal cortex by Uzuneser, Taygun C, Szkudlarek, Hanna J, Jones, Matthew J, Nashed, Mina G, Clement, Timothy, Wang, Hehe, Ojima, Iwao, Rushlow, Walter J, Laviolette, Steven R

    Published in Cerebral cortex (New York, N.Y. 1991) (10-03-2023)
    “…Abstract The endocannabinoid (eCB) system represents a promising neurobiological target for novel anxiolytic pharmacotherapies. Previous clinical and…”
    Get full text
    Journal Article
  12. 12

    THC and CBD produce divergent effects on perception and panic behaviours via distinct cortical molecular pathways by Szkudlarek, Hanna J., Rodríguez-Ruiz, Mar, Hudson, Roger, De Felice, Marta, Jung, Tony, Rushlow, Walter J., Laviolette, Steven R.

    “…•Intra-PFC infusion of THC and CBD lead to divergent behavioural and molecular profiles.•THC facilitates panic-like behaviour that can be prevented by…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Opiate exposure state controls dopamine D3 receptor and cdk5/calcineurin signaling in the basolateral amygdala during reward and withdrawal aversion memory formation by Rosen, Laura G., Rushlow, Walter J., Laviolette, Steven R.

    “…The dopamine (DA) D3 receptor (D3R) is highly expressed in the basolateral nucleus of the amygdala (BLA), a neural region critical for processing…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Adolescent nicotine induces depressive and anxiogenic effects through ERK 1‐2 and Akt‐GSK‐3 pathways and neuronal dysregulation in the nucleus accumbens by Hudson, Roger, Green, Matthew, Wright, Daniel J., Renard, Justine, Jobson, Christina E.L., Jung, Tony, Rushlow, Walter, Laviolette, Steven R.

    Published in Addiction biology (01-03-2021)
    “…Long‐term tobacco dependence typically develops during adolescence and neurodevelopmental nicotine exposure is associated with affective disturbances that…”
    Get full text
    Journal Article
  17. 17

    NMDA Receptor Blockade in the Prelimbic Cortex Activates the Mesolimbic System and Dopamine-Dependent Opiate Reward Signaling by Tan, Huibing, Rosen, Laura G., Ng, Garye A., Rushlow, Walter J., Laviolette, Steven R.

    Published in Psychopharmacology (01-12-2014)
    “…Rationale N-Methyl- d -aspartate (NMDA) receptors in the medial prefrontal cortex (mPFC) are involved in opiate reward processing and modulate sub-cortical…”
    Get full text
    Journal Article
  18. 18

    Activation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled-3 by Sutton, Laurie P, Honardoust, Dariush, Mouyal, Joanne, Rajakumar, Nagalingam, Rushlow, Walter J

    Published in Journal of neurochemistry (01-07-2007)
    “…Protein kinase B (Akt), glycogen synthase kinase-3 (GSK-3) and members of the Wnt signal transduction pathway were recently found to be altered in…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Regulation of Akt and Wnt signaling by the group II metabotropic glutamate receptor antagonist LY341495 and agonist LY379268 by Sutton, Laurie P., Rushlow, Walter J.

    Published in Journal of neurochemistry (01-06-2011)
    “…J. Neurochem. (2011) 117, 973–983. Metabotropic glutamate receptors 2/3 (mGlu2/3) have been implicated in schizophrenia and as a novel treatment target for…”
    Get full text
    Journal Article